chrisvoncsefalvay/vaers-outcomes huggingface dataset:
a little dizzy; felt very weak; felt really tired; nauseous; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (a little dizzy), ASTHENIA (felt very weak), FATIGUE (felt really tired) and NAUSEA (nauseous) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ATORVASTATIN for an unknown indication.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 03-Feb-2021, the patient experienced DIZZINESS (a little dizzy), ASTHENIA (felt very weak), FATIGUE (felt really tired) and NAUSEA (nauseous). At the time of the report, DIZZINESS (a little dizzy), ASTHENIA (felt very weak), FATIGUE (felt really tired) and NAUSEA (nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment information was provided as patient was given antivertigo medication medicine.; Sender's Comments: Based on the current available information and temporal association between the use of mRNA-1273 and the onset of the events, a causal relationship cannot be excluded. Fatigue and nausea are consistent with the product safety profile
Myalgia, Fever, NauseaVomiting,  Chills, Narrative:  Received shot at 1130 1/26/21 and by midnight started experiencing emesis, myalgias and chills. The next 2 days experienced myalgias, fever (up to 102), nausea and vomiting. Symptoms resolved late afternoon 1/28/21. No known prior COVID infection.   Other Relevant History:
Aug 6.   Got vaccination, had arm pain at shot site in the evening Aug 7.   Pain in upper arm at shot site Aug 8.   Little less pain in upper arm at shot site Aug 9.   No symptoms Aug 10. No symptoms  Aug 11.  Swelling of lymph node in armpit. Pain & tightness in upper arm & armpit area Aug 12.  More swelling and painful lymph node, very swollen and painful Aug 13.  Little less swelling and pain in lymph node in armpit. Tender at shot site again, feels irritated. Aug 14.  Bullseye rash around shot site, painful and tender, itchy, feels hot and hard. Little less pain and swelling in lymph node in armpit. Sharp shooting pain in my lymph node a few times. Aug 15.   Bullseye rash spread larger, still hot & hard, painful, tender & itchy. Lymph node still swollen and painful. Sharp shooting pain in lymph node a few times. Aug 16.   Bullseye rash spread larger, not as hot & hard or painful, itchy around the edges. Lymph node little less swollen and painful, still uncomfortable. Aug 17.   Bullseye rash spread larger, much less painful, little less hard and hot feeling. It has a defined edge around the circle of the rash and the edges are itchy. Lymph node a little less swollen and painful.
This case was reported by a consumer via call center representative and described the occurrence of fever in a patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, unknown after receiving SHINGRIX, the patient experienced fever, pain in arm, headache, tiredness, pruritus and pins and needles. On an unknown date, the outcome of the fever, pain in arm, headache, tiredness, pruritus and pins and needles were unknown. It was unknown if the reporter considered the fever, pain in arm, headache, tiredness, pruritus and pins and needles to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient's fingers feel like pins and needles poking the fingers and they itch bad. The patient also had many of the other problems that come with that headache, tired, sore arm and fever, this was all from shingles booster shot.
Had a very sore left arm for about 3 days after dose 1and dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 11Sep2021 13:30 (Lot number: FF2587) at the age of 44 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Fibromyalgia" (unspecified if ongoing); "High blood pressure" (unspecified if ongoing); "Gerd" (unspecified if ongoing); "Depression" (unspecified if ongoing); "Anxiety" (unspecified if ongoing); "Painful periods" (unspecified if ongoing); "Penicillin" (unspecified if ongoing). Concomitant medication(s) included: GABAPENTIN; DULOXETINE; AMBIEN; TOPIRAMATE; WELLBUTRIN. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "recovered" (2021), described as "Had a very sore left arm for about 3 days after dose 1and dose". Therapeutic measures were not taken as a result of pain in extremity.  Additional information: the patient later received dose 2 of bnt162b2 on 04Oct2021 15:00, batch/lot number: AA16607 in arm left and about 3 hours after the injection, the site was very red, hot, swollen. It was bigger than the size of a half dollar. It became extremely itchy. She had very sore left arm. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  Follow-up attempts are completed. No further information is expected.
drooping of face on right side- diagnosed in ER on 3-14 at Bell's Palsey
No additional adverse events reported; The patient was receiving several unspecified vaccines and the medical assistant who was administering them wanted separate sites for each so used the gluteus maximus for the VAQTA; who was administering them wanted separate sites for each so used the gluteus maximus for the VAQTA; This spontaneous report as received from a medical assistant refers to a 21 year old female patient of unknown age. There was no information about the patient's medical history or concurrent conditions. Concomitant therapies include several unspecified routine vaccines. An adult dose of hepatitis a vaccine, inactivated(VAQTA) was administered in the gluteus maximus (lot # S037821, expiration date. 07-JAN-2021) (dose and frequency were not reported) for prophylaxis, on 13-OCT-2020. The patient was receiving several unspecified vaccines and the medical assistant who was administering them wanted separate sites for each so used the gluteus maximus for the of hepatitis a vaccine, inactivated (VAQTA)(Off label use), on the same date. No additional adverse events reported.
The patient was accidently given a COVID Bivalent Booster in addition to the Flucelvax vaccine.  The patient had already received the COVID Bivalent Booster on 10/02/2022.  When the patient left, they had not experienced any adverse health events (Item #21 should be marked as unknown at this time).
After first dose: burning mouth syndrome, starting with sensitive inner lips. Immediately after second dose: burning was spreading to tip and sides of tongue. About two weeks after the second dose, the burning was spreading to outer lips, palate, throat and esophagus. Talking is especially painful to the tongue. The burning is always there but wanders around a little, sometimes the whole tongue, sometimes just the tip, sometimes also the lips and sometimes just the tongue, but most days the burning is everywhere. No treatment worked to ease the burning and the pain. Blood test came back normal. After nine weeks, the ear, nose & throat specialist, did also not see anything wrong in my mouth.
pt recv vax 13MAY98 210PM & by 5:00-5:30 had swelling, redness & apparent tenderness;did not allow this to be touched;@ appt 2cm area of erythema;
Left arm brachial neuritis. Developed 4 days after receive annual influenza vaccine. Left arm weakness and pain. Currently taking pain medication (Lyrica, Tramadol). He has been in physical therapy 6/27/08 Reviewed clinic vax records & medical records 11/9/2007-5/19/08.   FINAL DX: left idiopathic brachial plexitis r/t influenza vaccination. Note of 11/9 reveals patient experienced left arm pain day after vaccination which continued to worsen w/decreased mobility & then unable to lift left arm.  Included left upper back, shoulder & deltoid aching & tingling w/occasional sharp shooting pain.  Had to use right arm to lift left arm above chest level.  Referred to neurology.  Very slowly improving w/meds & PT.
Pharmacist accidentally drew up the dose of 0.3 mL from an undiluted orange cap pediatric vial. Luckily, since undiluted, the concentration is exactly the same as the adult vaccine, so the patients did receive the inteded 30 mcg adult dose. No repeat dosing recommended.
This case was reported by a consumer via interactive digital media and described the occurrence of blister in a female patient who received SHINGRIX. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, 21 days after receiving SHINGRIX, the patient experienced blister and pruritus. On an unknown date, the outcome of the blister and pruritus were unknown. It was unknown if the reporter considered the blister and pruritus to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient stated that after having had chicken pox as a junior high student, and know many with very painful case of shingles, the patient got the SHINGRIX about 3 weeks ago from the time of reporting. On the day of reporting in the morning the patient had noticed a couple itchy blisters, then more areas had developed. The patient asked if it was possibly a side effect. The patient was not sure if it was reaction to vaccine or allergy to something else but just realized it could be and said SHINGRIX was not a live vaccine though.
sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A 58 year-old female patient received bnt162b2 (BNT162B2), administration date 03Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "rheumatoid arthritis" (unspecified if ongoing), notes: She has a couple of autoimmune disorders, rheumatoid arthritis and bilateral polyneuropathy, plus COPD. "bilateral polyneuropathy" (unspecified if ongoing), notes: She has a couple of autoimmune disorders, rheumatoid arthritis and bilateral polyneuropathy, plus COPD.; "COPD" (unspecified if ongoing), notes: She has a couple of autoimmune disorders, rheumatoid arthritis and bilateral polyneuropathy, plus COPD. "Guillain-Barre syndrome" (unspecified if ongoing), notes: She is concerned because her condition is very similar to Guillain-Barre syndrome.; "autoimmune disorders" (unspecified if ongoing), notes: She has a couple of autoimmune disorders, rheumatoid arthritis and bilateral polyneuropathy, plus COPD. The patient's concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset Mar2021, outcome "unknown", described as "sore arm". Additional information:The patient received the first dose of Pfizer's vaccine yesterday, they gave her a booklet and a fact sheet where she saw she should mention to the provider that she's immunocompromised. She has a couple of autoimmune disorders, rheumatoid arthritis and bilateral polyneuropathy, plus COPD. Is it okay that she got the vaccine. She is concerned because her condition is very similar to Guillain-Barre syndrome. After the vaccine she has only had a sore arm. But she is concerned something else might go on. She was wondering if she might need a third dose at some point. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
?Pt received vaccine that was stored improperly. Vaccine was moved from ultra-cold freezer to freezer on 6/17/21. According to Pfizer, vaccine stored in the freezer after day 17 is considered improperly stored, and the pt will need to be re-vaccinated.?
I had a headache which was different from migraine. I went to the ER at a local hospital for headache symptoms hospitalized for four days then discharged. The following day went to my PCP ordered me a MRI prescribed me prednisone. Since August 2021 to October was placed back on prednisone for my headaches. I was admitted in December 2021 was admitted diagnosed with Meningitis and High intracranial pressure.
Erythema/edema left thigh at vaccination site.  Started on 04/28/04 with slight redness, 04/29/04 swollen and increased red.
When I received the first injection, 3.15.19,I reported to VAERS that I had a reaction.  VAERS ID: 805637 This injection, 7.19.19, right after I received it, I felt a little strange. Went home had dinner. Woke up the next morning and didn't want to get out of bed. Temp that day went up to 102. Very weak and tired. Slept a large part of the day. Could hardly move off couch. The second day after the shot the fever had gone away and was able to be up and around. Felt tired took a nap, which I usually don't do. Was very drepressed, till the 4th day after the shot started feeling like my old self.
fever 2 hrs p/shot; t101; hives started on back, spread chest, rt side of buttock; stiffness on lt side; h/a last noc;
Right after receiving the vaccine I had to drive an hour away to get home. Before I got home I was already feeling tired, fatigued, weak, and I had a sore arm. All I wanted to do was go to bed. Day 2 I started to get flu like symptoms that lasted for about a week. My arm started to get redder during the first week. Day 8 I ended up in the hospital because I couldn't breathe and my arm was really red and infected. The doctors gave me antibiotics and IVs to treat it. They gave me antibiotics for 10 days and then my arm started to get better. I can still feel the lump on my arm  where I got the vaccine, but it doesn't bother me anymore. I don't feel like I have fully recovered from my breathing issues and they have gotten worst since I got the vaccine. I didn't get the second dose because my doctor said the second dose could be worst than the first one because of my reaction I already had from the first dose. They said my body isn't ready right now to get the second dose, but I could possibly get it some time later. I'm not against getting the vaccine I'm just a little scared of getting it because of what I have already experienced with the first dose.
Severe shingles lasting several months.  Now less severe.  Need to know about future vaccinations or other options.  Also doctors, pharmacists and lab may be misinformed about antibody tests which indicate first vaccine didn?t work.
Immediately had a headache and nausea.  That evening pain all down left arm. Later still nauseous and felt hot. During night muscle and joint pain, chills and sweating. Next day fever, headache, severe pain in left arm,  nauseous, whole body pain.
Left breast cancer, grade 2-3, two masses next to each other. Larger mass (1.4cm):ER+, PR+, HER2+, smaller mass (1cm): ER+, PR-,HER2+. Chemotherapy and targeted medication treatment, Lumpectomy (January 2022), next steps: radiation and further combined chemo and targeted medication for a year
At about 12 noon, 8/22/08, Res noted to have approximately 7cm circular raised red rash with swollen fingers with rash on right upper extremity - right deltoid area also had .3cm pimple type lesion at its center.  Rash also later noted under left breast, abdomen.  Res c/o achiness on 8/23/08.  1730, Res rash worsened extended to her buttocks.  Benadryl Rx by MD.  8/25 doctor stated rash around pneumovax injection site, now generalized macular, papular, erythremia.  8/28/08 last dose of Benadryl - rash improved.
mom states approx 330Pm started crying-abn cry-nothing consoled;cried till 8PM;mom states did not try & feed during that period of time
Fever, pain - several hr after receiving vaccine. 2 days later increased pain at site of vaccine.
Patient is a very pleasant 62 year old gentleman with a history of HTN, hyperlipidemia who presented with left facial numbness and left UE numbness. He states that it is worse medially on his arm. Present in upper and lower face. He states it started around 730 am this morning. He also notes intermittent "foggy" sensation since Monday associated with some blurred vision that comes and goes. Denies focal weakness, unsteady gait, difficulty with speech and swallow. He denies f/c, cp, sob, rash, pruritis, n/v/d, edema. He did receive the Pfizer COVID vaccine yesterday
MIGRAINE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 10-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company was unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 10-MAR-2021, the subject experienced migraine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from migraine. This report was non-serious.
Patient became dizzy and weak a few minutes after shot.  She started to see spots and felt like she was going to faint, she was sitting and we brought extra chair for her to put up legs.
a couple days after booster a small rash the size of a dime was noticed on my left heel. Then it turned into itchy rash on my feet with large blisters then just progress to hands , legs, back. Still ongoing. doctor has said that it is eczema .Never had any signs of any thing like this before
Left lower (outer) aspect of upper arm swollen, red and painful when pressure applied. Sx. started 1 day after injection. No Tx reported.
Pt with erythema, edema, pain RUE with paresthesia and temporary immobility in all 20 phalanges. Tx: Motrin, Warm compresses.
Received 1st HPV9 vaccine - a few hours later developed a rash which became generalized, erythematous and urticaric - improved after BENADRYL the following day. Seen by provider.
Severe myalgia, headache, dizziness, fatigue, nausea, GI cramping, chills for 36 hours Headache persistent through today mild myalgia persistent through today
Morning following vaccination, severe diarrhea - musche aches, chills, dizzy, light headedness X 1 day.  Weakness, generalized 2 days.
COVID-19; COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Physician). The reporter is the patient.  A 74-year-old male patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of covid-19.  Clinical course: Patient had no other medication in 2 weeks. Patient had none known allergies and no other medical history. Patient was in good health.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
redness at the site; redness at the site which was itchy; Low grade fever; had "a possible allergic reaction,"; redness spread further on the arm; The area looked ike a bruise,; warm to touch; This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 17th February 2020, the patient received the 1st dose of Shingrix. On 18th February 2020, 1 days after receiving Shingrix, the patient experienced injection site erythema, injection site itching, low grade fever, allergic reaction, erythema of extremities, injection site bruising and injection site warmth. On 19th February 2020, the outcome of the injection site itching was resolved with sequelae. On an unknown date, the outcome of the injection site erythema, low grade fever, allergic reaction, erythema of extremities, injection site bruising and injection site warmth were unknown.   It was unknown if the reporter considered the injection site erythema, injection site itching, low grade fever, allergic reaction, erythema of extremities, injection site bruising and injection site warmth to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received the dose of Shingrix and the next day had a possible allergic reaction, further described as redness at the site which was itchy, the area looked like a bruise, it was warm to touch, and she also experienced a low grade fever.  The redness spread further on the arm the patient The itching had resolved.  The reporter would classify the reaction as mild. The follow up consent was granted. .
Fever - highest 101.7; Muscle and joint aches and pain; Severe headaches; Elevated heart rate; Joint ache and pain; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6198) via an unspecified route of administration in the right arm on 16Mar2021 at 10:00AM (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patients medical history and concomitant medication were not reported. Patient was not allergic to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID-19 post vaccination. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the right arm on 23Feb2021 as a single dose for COVID-19 immunisation. On 17Mar2021 at 06:00AM, the patient experienced Fever - highest 101.7 (units unspecified), Muscle and joint aches and pain, Severe headaches and Elevated heart rate. The patient did not receive any treatment for the reported events. The clinical outcome of the event Fever - highest 101.7, Muscle and joint aches and pain, Severe headaches and Elevated heart rate was recovering.   No follow-up attempts are needed. No further information is expected.
Fever, shivers, soreness, and fatigue. After a few days a rash formed around the arm where shot was given.
Fatigue, Chills, Headache, Upset stomach, sluggish  2nd dose given earlier that day
On 2/8/00, child became fussy at Preschool at 11:00am & mom picked up pt, took temp at home at 1:00pm, 99F, at 2pm, 103.4. Pt taken to DR & temp was 104.3F at 2:35pm. No other sx's. Dr examined pt & gave children's Advil.
Information has been received from a physician concerning a 20 year old female employee who on 16Feb1999 and 22Mar1999 was vaccinated with a first and second dose of varicella virus vaccine live. One lot number was reported to be 628694/1663H, however the dose corresponding to this lot number was not specified. It was reported that the pt had an inconclusive low titer to varicella despite the two dose and that there was a vaccine failure. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Persistant dizziness for several days, prevented her from working for 1-2 days